Nashville Early Diagnosis Lung Cancer Project
Sponsor: National Cancer Institute (NCI)
A observational or N/A phase clinical study on Lung Cancer, this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 16 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Nov 2022 — Jan 2024 [monthly]
Active Not Recruiting
-
Dec 2021 — Nov 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 11 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
Status: Suspended → Recruiting
-
May 2020 — Jun 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Jun 2019 — May 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Vanderbilt-Ingram Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .